Search Results 371-380 of 16772 for alt

1. Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia - Mayo Clinic

   Aspartate aminotransferase (AST), alanine aminotransferase (ALT) =< 3 x upper limit of normal (ULN), unless suspected leukemic involvement of the liver.

2. A Study of Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M) - Mayo Clinic

   ... (ALT) ≤ 3 times ULN (AST and ALT ≤ 5 times ULN in case of liver metastases). Baseline blood manganese (Mn) level < 2.0 times ULN. For patients with a ...

3. PORtopulmonary Hypertension Treatment WIth MaCitentan ─ A RandOmized Clinical Trial - Mayo Clinic

   ALT/AST >= 3 x ULN; Bilirubin >= 3 mg/dL at Screening; Any known factor or disease that might interfere with treatment compliance, study conduct, or ...

4. Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19) (enrollment by invitation only) - Mayo Clinic

   ALT or AST > 5 x ULN. Creatinine clearance < 50 mL/min using the Cockcroft-Gault formula for participants ≥ 18 years of age {Cockcroft 1976} and Schwartz ...

5. Humans With Obesity Response to Exercise - Mayo Clinic

   ... (ALT) \>165 IU/L) * Oral warfarin group medications or history of blood clotting disorders. * Smoking * Pregnancy or breastfeeding * Alcohol consumption ...

6. A Study to Evaluate Fostamatinib Disodium to Treat Warm Antibody Autoimmune Hemolytic Anemia - Mayo Clinic

   ... [ALT] or aspartate aminotransferase [AST]) > 1.5 x ULN. Has documented active hepatitis B or hepatitis C infection or HIV infection. Participating Mayo ...

7. A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03) - Mayo Clinic

   ... ALT < 3 × ULN that are not attributable to HBV infection), and are willing to start and maintain antiviral treatment for the duration of the study, are allowed.

8. A Study of ONO-7475 in Patients With Acute Leukemias - Mayo Clinic

   AST and ALT ≤ 2.5 x ULN;; Calculated creatinine clearance ≥ 45 mL/min.;; Serum albumin ≥ 2.5 g/dL. For any patient with laboratory values outside the ...

9. Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis - Mayo Clinic

   ALT >3 times upper limit of normal (ULN) or AST >5 times ULN during screening. Initiation or discontinuation of non-selective beta blockers within 1 month ...

10. A Study To Assess The Effectiveness, Safety And Tolerability Of Dupilumab In Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) With Type 2 Inflammation - Mayo Clinic

    Alanine transaminase (ALT) > 3 times upper limit of normal range (ULN);; Hemoglobin < 10g /100 mL for male and < 9g/ 100 mL for female;; Platelets < 100 000 ...